Article

Integrated Plasma and Urinary Cell-free DNA Profiling Enables Noninvasive Molecular Detection from Ta to T4 Bladder Cancer

2026-07-15

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and Objective</h4> Due to the heterogeneity of bladder cancer, minimally invasive molecular profiling may improve tumor characterization at the time of diagnosis. We evaluated whether integrated genomic and fragmentomic profiling of plasma and urinary circulating tumor DNA (ctDNA) detects BC-derived signals for diagnosis and disease stratification across all tumor stages. <h4>Met...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9adf6adf-efe2-5edc-83fb-48f47341a804
DOI: 10.64898/2026.07.13.26357430

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrated Plasma and Urinary Cell-free DNA Profiling Enables Noninvasive Molecular Detection from Ta to T4 Bladder CancerDOI 10.64898/2026.07.13.26357430Read

The evolving landscape and clinical utility of circulating tumor DNA across the spectrum of urothelial carcinoma: A systematic review and framework for clinical integration.Semantic proximity Read

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity Read

Circulating Tumor DNA in Genitourinary Malignancies: Current Applications and Future PerspectivesSemantic proximity Read

Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.Semantic proximity Read

Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patientsSemantic proximity Read

Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer ManagementSemantic proximity Read

Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A ReviewSemantic proximity Read

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNASemantic proximity Read

Liquid Biopsy in Genitourinary Cancers: Circulating Tumor DNA as a Predictive Biomarker for Treatment Selection and Resistance MonitoringSemantic proximity Read

Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patientsSemantic proximity Read

Tumor heterogeneity and the potential role of liquid biopsy in bladder cancerSemantic proximity Read

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.Semantic proximity Read